OMEROS CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Omeros Corporation on August 10, 2010. The filing serves to announce financial results for the three and six months ended June 30, 2010. The company is incorporated in Washington and maintains its principal executive offices in Seattle.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It directs readers to the attached press release for the comparative financial results.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in this Current Report and the accompanying exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933 and shall not be incorporated by reference into any other SEC filing by Omeros.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 10, 2010) for specific revenue, net loss, and cash position figures.
- Verify the specific clinical trial progress or regulatory updates mentioned in the press release, as these are typical drivers for Omeros' financial condition.
- Confirm the company's cash runway and burn rate as detailed in the full financial statements referenced in the exhibit.
- Note the legal disclaimer regarding the non-filing status of the exhibit for liability purposes.